GlassScriptPhysician profile
David T Kelter
NPI 1770148181
$2,944.46
in general payments reported to CMS, 2019-2025
11 companies · $732 in 2025
The $732 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $2,212 · 2025: $732.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,757 · Travel and Lodging: $817 · Education: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,756.85 |
| Travel and Lodging | $817.33 |
| Education | $370.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Enterra Medical, INC. | $1,403.12 | 2024 | |
| W. L. Gore & Associates, INC. | $791.09 | 2024-2025 | Gore Synecor Biomaterial, Gore Synecor Preperitoneal Biomaterial |
| Davol INC. | $194.71 | 2025 | Arista, Channel Drain, Phasix Mesh |
| Medtronic, INC. | $156.91 | 2024-2025 | Progrip, Signia |
| Sanara Medtech INC. | $150.73 | 2024 | Celleraterx |
| Ethicon US, LLC | $76.65 | 2025 | Vistaseal |
| Medical Device Business Services, INC. | $73.96 | 2025 | Surgiflo Hemostatic Matrix |
| Innovation Technologies INC | $28.28 | 2024 | Irrisept |
| Histosonics, INC. | $25.93 | 2025 | |
| Kerecis Limited | $22.74 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Merck Sharp & Dohme LLC | $20.34 | 2024 | Pifeltro, Delstrigo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kelter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.